In addition, we chose clinical outcome measures such as AKI and RRT instead of biochemical markers, such as serum creatinine values, calculated creatinine clearance, urinary neutrophil gelatinase-associated lipocalin and cystatin C ratio, to assess the renal safety. This evidence concerns the gene CST3 and acute kidney injury.